delphinidin has been researched along with Gammapathy, Monoclonal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baldet, P; Brochier, J; Costes, V; Durand, L; Klein, B; Legouffe, E; Magen, V; Rossi, JF | 1 |
1 other study(ies) available for delphinidin and Gammapathy, Monoclonal
Article | Year |
---|---|
The Mi15 monoclonal antibody (anti-syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens.
Topics: Antibodies, Monoclonal; Biopsy; Bone Marrow; Cell Count; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma, B-Cell; Lymphoma, T-Cell; Membrane Glycoproteins; Multiple Myeloma; Neoplasms; Paraffin; Paraproteinemias; Plasma Cells; Plasmacytoma; Proteoglycans; Syndecan-1; Syndecans; Tissue Embedding | 1999 |